Figure 2From: A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transitionReduction of HPSE activity by GAG mixtures. Graphs showing the percentage of residual heparanase enzyme activity after incubation with sulodexide and parnaparin + DS in proportions of 20:80, 50:50 and 80:20, at concentrations of 5, 10, 20 and 50 μg/ml ± SD.Back to article page